August 2010 Contents
Cover Story
Beyond the paradox of progress
Jamal Gasmi, MD, PhD Oncology, Icon Clinical Research & James Conklin, MD, Icon Medical Imaging
In the race to identify targets for anticancer therapies, the role of biomarkers in oncology drug development becomes vital.
Drug Manufacturing
Seamless cold chains
Rolf D Sulser, in collaboration with Panalpina
Transportation of temperature-sensitive pharmaceutical products poses a crucial challenge. One way to overcome it is to utilise the technology of active temperature control.
On the trail of acquisitions
Hedwig Kresse, head of vaccines and infectious diseases, Datamonitor
Abbott's flu vaccine business may represent a good deal for acquisitive drug makers.
Editor''s Note
Facing down killer diseases
Lee Kok Leong, Editor
Global News
A*Star scientists make breakthroughs against cancer
Majority of sales derives from mature drugs
Booming life science industry
Drug Discovery
Reaching boiling point
Rob Darrington, marketing & business development manager, Genevac
The removal of solvents from thermolabile samples by centrifugal evaporation has been well established. However, evaporator technology is put to the challenge when dealing with high boiling point solvents.
Special Report
Getting to the heart of CVD
Cardiovascular diseases are the world's leading cause of death. Experts and journalists from around the world converge on Beijing for the World Congress of Cardiology Bayer scientific roundtable to discuss the problem. LEE KOK LEONG travels to China to report.
Show Review
An alliance made in Tianjin
Icon Central Laboratories in collaboration with Fountain Medical Development have opened a laboratory in Tianjin, China. LEE KOK LEONG interviews TOM O'LEARY, president, Icon Central Laboratories.
Product Focus
Genevac: high capacity biological sample concentrator
SP Scientific: temperature control system
Agilent: 1260 Infinity LC offers rapid resolution power
